nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Central sympathoinhibitory effects of calcium channel blockers
|
Leenen, Frans H. H. |
|
2001 |
3 |
4 |
p. 314-321 |
artikel |
2 |
Do most antihypertensive agents have a sympatholytic action?
|
Champlain, Jacques de |
|
2001 |
3 |
4 |
p. 305-313 |
artikel |
3 |
Lessons learned from prematurely terminated clinical trials
|
Sica, Domenic |
|
2001 |
3 |
4 |
p. 360-366 |
artikel |
4 |
Literature alert
|
|
|
2001 |
3 |
4 |
p. 275-276 |
artikel |
5 |
Prospectively designed overviews of recent trials comparing antihypertensive regimens based on different drug classes
|
Chapman, Neil |
|
2001 |
3 |
4 |
p. 340-349 |
artikel |
6 |
Salt and blood pressure: What’s new?
|
Weinberger, Myron H. |
|
2001 |
3 |
4 |
p. 271-272 |
artikel |
7 |
Statins and blood pressure regulation
|
Borghi, Claudio |
|
2001 |
3 |
4 |
p. 281-288 |
artikel |
8 |
The antiatherogenic effects of antihypertensive treatment: Trials completed and ongoing
|
Zanchetti, Alberto |
|
2001 |
3 |
4 |
p. 350-359 |
artikel |
9 |
The benefit of treating isolated systolic hypertension
|
Wang, Ji-Guang |
|
2001 |
3 |
4 |
p. 333-339 |
artikel |
10 |
The effect of antihypertensive drugs on vascular compliance
|
Winer, Nathaniel |
|
2001 |
3 |
4 |
p. 297-304 |
artikel |
11 |
The INSIGHT and NORDIL trials: Are calcium antagonists equivalent to established drug therapies for cardiovascular protection?
|
Ruddy, Michael C. |
|
2001 |
3 |
4 |
p. 289-296 |
artikel |
12 |
The therapeutic potential of endothelin receptor antagonists in cardiovascular disease
|
Barton, Matthias |
|
2001 |
3 |
4 |
p. 322-330 |
artikel |
13 |
Web alert
|
|
|
2001 |
3 |
4 |
p. 273-274 |
artikel |
14 |
When can treatment of hypertension be stopped?
|
Weber, Michael A. |
|
2001 |
3 |
4 |
p. 279-280 |
artikel |